Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Early and treatment-relat… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.

Artikel i vetenskaplig tidskrift
Författare Lene Molgaard-Hansen
Merja Möttönen
Heidi Glosli
Guðmundur K Jónmundsson
Jonas Abrahamsson
Henrik Hasle
Lotta Mellander
Publicerad i British journal of haematology
Volym 151
Nummer/häfte 5
Sidor 447-59
ISSN 1365-2141
Publiceringsår 2010
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för pediatrik
Sidor 447-59
Språk en
Länkar dx.doi.org/10.1111/j.1365-2141.2010...
Ämnesord Adolescent, Age Distribution, Antineoplastic Combined Chemotherapy Protocols, adverse effects, therapeutic use, Child, Child, Preschool, Epidemiologic Methods, Finland, epidemiology, Heart Failure, chemically induced, mortality, Humans, Iceland, epidemiology, Infant, Leukemia, Myeloid, Acute, drug therapy, mortality, Opportunistic Infections, mortality, Scandinavia, epidemiology, Sex Distribution, Time Factors
Ämneskategorier Cancer och onkologi, Barn

Sammanfattning

Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analysed the frequency, clinical features and risk factors for early deaths (ED) and treatment-related deaths (TRD) in 525 children included in the Nordic Society of Paediatric Haematology and Oncology (NOPHO)-AML-84, -88 and -93 trials. Seventy patients (13%) died before starting treatment or from treatment-related complications. The death rate rose from 11% in NOPHO-AML-84 to 29% in -88, but then fell to 8% in -93. Sixteen patients (3%) died within the first 2 weeks, mainly from bleeding or leucostasis. Hyperleucocytosis, age <2 or ≥10 years were risk factors. After day 15, 10% of patients died from treatment-related complications with infection as the main cause of death. Risk factors were age <2 or ≥10 years and treatment according to the NOPHO-AML-88 protocol. The number of EDs and TRDs in AML is high. Therefore optimal antifungal prophylaxis is essential, and studies on the benefit of antibacterial prophylaxis and individual risk factors for ED and TRD are needed.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?